Dr Reddy's Labs to acquire OctoPlus NV for euro 27.4 million
Quotes

Dr Reddy's Labs to acquire OctoPlus NV for euro 27.4 million

Last Updated: Monday, October 22, 2012, 09:59
 
 Comment 0
 
Dr Reddy's Labs to acquire OctoPlus NV for euro 27.4 million
Hyderabad: Drug maker Dr Reddy's Laboratories on Monday said it has decided to acquire Netherlands-based OctoPlus NV, a speciality pharmaceutical company, for about 27.4 million euros (about Rs 193 crore).

In a joint statement with OctoPlus, DRL said both the companies have reached conditional agreement in connection with an intended public offer by DRL or a wholly owned subsidiary of DRL, for all issued and outstanding ordinary shares in the capital of OctoPlus at an offer price of 0.52 euro in cash for each OctoPlus share.

Chief Executive Officer and Vice Chairman of Dr Reddy's Lab G V Prasad said: "We are happy to have an R&D base in the Leiden area (The Netherlands) and the acquisition gives us the ability to strengthen our technological capabilities in the areas of drug delivery."

The offer values 100 percent of the issued and outstanding ordinary shares of OctoPlus at 27.4 million euros, the statement added.

CEO of OctoPlus Jan Egberts said, "We are proud of the confidence Dr Reddy's has shown in our organisation. It reflects the success of the major operational and organisational improvements we have implemented over the past few years."

Shares of DRL were trading at Rs 1,710 apiece on the BSE in the early trade.

PTI




First Published: Monday, October 22, 2012, 09:59


Comments


comments powered by Disqus
India`s top ten billionaires
India`s top ten billionaires
Pradhan Mantri Jan Dhan Yojana - In Pics
Pradhan Mantri Jan Dhan Yojana - In Pics
Apple Smartwatch unveiled
Apple Smartwatch unveiled
Apple iPhone 6, iPhone 6 plus
Apple iPhone 6, iPhone 6 plus
Samsung Galaxy Tab 4 Nook
Samsung Galaxy Tab 4 Nook

Web Wrap
Contact Us : Privacy Policy : Legal Disclaimer
Copyright © Zee Media Corporation Ltd. All rights reserved